What is Quantum BioPharma Ltd. (QNTM) stock price today?

Quantum BioPharma Ltd. (QNTM) currently trades at $5.73 per share. The stock has a market capitalization of $31.77M and a P/E ratio of —x.

Is QNTM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Quantum BioPharma Ltd. has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -15.76.

Is Quantum BioPharma Ltd. financially healthy?

Quantum BioPharma Ltd.'s Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -15.76 places it in the distress.

QNTM

Quantum BioPharma Ltd.

NASDAQ: QNTM · HEALTHCARE · BIOTECHNOLOGY

$5.73

+1.42% today

Updated 2026-04-30

Market cap

$31.77M

P/E ratio

—

P/S ratio

91.86x

EPS (TTM)

$-8.20

Dividend yield

—

52W range

$2 – $38

Volume

0.5M

Market cap

$31.77M

P/E ratio

—

P/S ratio

91.86x

EPS (TTM)

$-8.20

Dividend yield

—

52W range

$2 – $38

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-15.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$12.75

+122.51%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.30x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -15.76 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-305246.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-23.61M	$-17.90M	$-14.20M	$-26.63M	$-3.07M
EPS	—	—	—	—	$-8.20
Free cash flow	$-28.70M	$-10.83M	$-6.88M	$-8.38M	$-305246.00
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
QNTM	$31.77M	20	4.3	3.0	5.0	4.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Quantum BioPharma Ltd. trades at $5.73. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -15.76, it sits in the distress.

Frequently asked questions

What is Quantum BioPharma Ltd.'s stock price?

Quantum BioPharma Ltd. (QNTM) trades at $5.73.

Is Quantum BioPharma Ltd. overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of Quantum BioPharma Ltd. (QNTM)?

The analyst target price is $12.75, representing +122.5% upside from the current price of $5.73.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-15.76 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.quantumbiopharma.com

Quick metrics

P/S ratio91.86x

ROE-346.90%

Beta0.29

50D MA$3.50

200D MA$10.81

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

QNTM vs LLY →QNTM vs JNJ →QNTM vs ABBV →Stock screener →